Remidio Innovative Solutions today announced the publication of a landmark independent evaluation of regulatory-approved diabetic retinopathy (DR) artificial intelligence algorithms in The Lancet Digital ... Jan 23
Myopia is rising at an unprecedented rate globally, affecting nearly 30 percent of the world’s population today and projected to reach 50 percent by ... Dec 19
Infants born prematurely—before 34 weeks of gestation or weighing less than 2000 grams at birth—are at high risk of developing several health complications.... Nov 19
Remidio Innovative Solutions, a leader in AI-powered ophthalmic devices, today announced the launch of Neubo 130, a next-generation ultra-widefield neonatal retinal imaging ... Nov 07
Medios HI detects both glaucoma and diabetic retinopathy from the same retinal image offline in under 10 seconds, reinforcing Remidio’s position as India’s ... Oct 22
Pristine Sets New Benchmark in In-Clinic Diagnostics with Multi-Modality Precision and Seamless Workflow.... May 21
With these approvals, Remidio continues to lead in the development of AI-driven ophthalmic diagnostics, aiming to bridge the gap in eye care delivery and ... May 02
Remidio Innovative Solutions, a global leader in AI-powered ophthalmic diagnostics, has announced a strategic partnership with RetinaRisk, a leading health tech company from Iceland, ... Apr 15
Strategic Partnership to Advance Early Disease Detection with Cutting-Edge Optical Technology.... Mar 25
By combining artificial intelligence with medical expertise, Kerala is showing the world how to create a smarter, more efficient, and patient-centric healthcare system.... Feb 24
DRDO, Research Centre Imarat (RCI), has developed an automated contact less UVC sanitisation cabinet, called Defence Research Ultraviolet Sanitiser (DRUVS). It has been designed to ... May 11
Primary-care based Diabetic Retinopathy (DR) screening can enable early detection, avoiding blindness due to DR for close to 425 million people living with diabetes ... Oct 10
The MEDIOS-AI, designed by Bangalore-based Remidio Innovative Solutions, will implement sensitive and scalable screening models for Diabetic Retinopathy.... Sep 27
Diabetic Retinopathy (DR), is asymptomatic and affects nearly 20% of the 70 million diabetic patients in India. ... Sep 11
-Advertisements-